UNSPSC 51383003: Tomoxiprole

This classification denotes a cyclooxygenase inhibitor with the molecular formula C21H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EZ948T2878, chemically known as 3-isopropyl-2-(p-methoxyphenyl)-3h-naphth(1,2-d)imidazole but generally known as tomoxiprole, which bears US NIH Compound Identifier 53454. European Medicines Agency schedules Tomoxiprole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11187MIG.

UNSPSC 51383003 Tomoxiprole, a Commodity code, does not align with the recent state and local procurement activity tagged to it. The single recent opportunity sourced under this code — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023 — solicits naloxone and safe drug deactivation systems for community health initiatives, not tomoxiprole. The mismatch suggests either a classification error in the county's e-Procurement system or a data tagging anomaly. Tomoxiprole, a veterinary antibiotic, bears no functional relation to naloxone (an opioid antagonist used in overdose response) or drug deactivation equipment.

The Seminole County procurement represents community health supply acquisition by a county health department rather than pharmaceutical procurement typical of a tomoxiprole commodity code. Without additional recent opportunities properly tagged to the code, the source provides insufficient basis to characterize state and local buying patterns, issuing-body mix, or geographic concentration for tomoxiprole. The code shows little relevant recent activity in the state and local procurement marketplace.